Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 08/26 10:00:08 pm
119.04 USD   +0.40%
08/26 JONSON AND JOHN : Depuy's Pinnacle Hip Replacement System
08/25 JOHNSON & JOHNS : JNJ) Janssen Biotech Inc. Files sBLA For DARZALEX
08/25 JOHNSON & JOHNS : Janssen Submits Application to the European Medici..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to nymonitoring@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
08/26 JONSON AND JOHNSON LAWSUIT : Depuy's Pinnacle Hip Replacement System
08/25 JOHNSON & JOHNSON : Announces Ruling Related to REMICADE® in the District of Mas..
08/25 JOHNSON & JOHNSON (NYSE : JNJ) Janssen Biotech Inc. Files sBLA For DARZALEX
08/25 JOHNSON & JOHNSON : MMIS President and CEO Michaeline Daboul to speak at CBI's 1..
08/25 JOHNSON & JOHNSON : Janssen Submits Application to the European Medicines Agency..
08/25 JOHNSON & JOHNSON : to Participate in the 2016 Wells Fargo 11th Annual Healthcar..
08/22 FOR U.S. MEDIA ONLY : Janssen Announces 25 Presentations at Upcoming ESC Congres..
08/21 JOHNSON & JOHNSON : With B.good, healthy eating comes to King of Prussia
08/21 JOHNSON & JOHNSON : Going from big pharma to farm-fresh
08/19 JOHNSON & JOHNSON : Diabetes Selfcare Demands Retail, Health Care Collaboration ..
More news
Sector news : Pharmaceuticals - NEC
12:53a Stada shareholder AOC pushes through board reshuffle
12:43a ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
08/26DJALERE : Sues Abbott to Force Merger -- 2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/26 Is Dow Theory Telling Us The Stock Rally Is Going To Fail?
08/25 88 Stock Picks For The Next 30 Years (Or More)
08/25 AGILENT TECHNOLOGIES INC. : A Total Return Technology Company (Part 1 Single Let..
08/25 Therapy Focus - Seeking Sustained Success In The Opioid Dependence Market
08/24 Merck Offers Value, Yield, And Reliable Dividends
Advertisement
Financials ($)
Sales 2016 72 068 M
EBIT 2016 21 808 M
Net income 2016 16 515 M
Finance 2016 13 074 M
Yield 2016 2,64%
P/E ratio 2016 20,18
P/E ratio 2017 17,83
EV / Sales 2016 4,32x
EV / Sales 2017 4,03x
Capitalization 324 393 M
More Financials
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 127 $
Spread / Average Target 6,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer
Susan L. Lindquist Independent Director
Charles O. Prince Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON15.43%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.62%213 882
PFIZER INC.7.71%211 206
MERCK & CO., INC.17.99%173 462
GLAXOSMITHKLINE PLC21.19%106 869
More Results